In a mixed lineage leukemia mouse model, mice treated with LSD1 inhibitor showed substantial decreases in leukemic cell proliferation, but the treated mice presented with greater levels of anemia and thrombocytopenia compared to vehicle-treated control mice (Harris et al., 2012). This evidence concerns the gene KDM1A and leukemia.